BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure

     BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure (press release) Patient Treatments of Bulging and Herniated Discs Show Promising Results Closing of License Grant Scheduled for March 2012 BioRestorative Therapies, Inc. (OTCQB: BRTX) ("BRT") today announced that it has entered into a License Agreement with Regenerative Sciences, LLC ("RS") with respect to certain stem cell-related technology and clinical treatment procedures developed by RS. The treatment is an advanced stem cell injection procedure that may offer relief from lower back pain, buttock...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top